G12V and G12A KRAS mutations are associated with poor outcome in patients with metastatic colorectal cancer treated with bevacizumab

Fiala, Ondrej, Buchler, Tomas, Mohelnikova-Duchonova, Beatrice · Tumor Biology · 2016